ANAB

26.21

0.15% 0.04

Handel nachbörslich: 26.21

Anaptysbio Inc (ANAB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$26.17

Offen:

$26.06

24-Stunden-Volumen:

480.66K

Relative Volume:

0.84

Marktkapitalisierung:

$770.06M

Einnahmen:

$17.16M

Nettoeinkommen (Verlust:

$-163.62M

KGV:

-4.3109

EPS:

-6.08

Netto-Cashflow:

$-121.61M

1W Leistung:

-1.58%

1M Leistung:

+13.12%

6M Leistung:

+61.99%

1J Leistung:

-26.60%

1-Tages-Spanne:

$25.48

$26.51

1-Wochen-Bereich:

$25.48

$27.46

52-Wochen-Spanne:

$12.21

$41.31

Anaptysbio Inc Stock (ANAB) Company Profile

Firmenname

Anaptysbio Inc

Sektor

Healthcare (1161)

Branche

Biotechnology (653)

Telefon

858-362-6295

Adresse

10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA

Mitarbeiter

136

Twitter

@anaptysbio

Nächster Verdiensttermin

2024-11-08

Neueste SEC-Einreichungen

ANAB's Discussions on Twitter

Vergleichen Sie ANAB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ANAB Anaptysbio Inc	26.21	782.40M	17.16M	-163.62M	-121.61M	-6.08
VRTX Vertex Pharmaceuticals Inc	470.13	119.21B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	560.93	59.16B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	325.28	40.57B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	571.23	34.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	295.59	29.19B	3.81B	-644.79M	-669.77M	-6.24

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-04	Hochstufung	H.C. Wainwright	Neutral → Buy
2025-02-04	Eingeleitet	Wolfe Research	Outperform
2024-12-11	Herabstufung	H.C. Wainwright	Buy → Neutral
2024-12-02	Herabstufung	BTIG Research	Buy → Neutral
2024-07-22	Eingeleitet	H.C. Wainwright	Buy
2024-07-19	Hochstufung	JP Morgan	Neutral → Overweight
2024-04-16	Eingeleitet	Leerink Partners	Outperform
2024-04-11	Eingeleitet	Wells Fargo	Overweight
2024-03-12	Hochstufung	Wedbush	Neutral → Outperform
2024-02-26	Eingeleitet	BTIG Research	Buy
2024-02-21	Eingeleitet	Stifel	Buy
2024-02-16	Eingeleitet	Piper Sandler	Overweight
2023-05-22	Hochstufung	JP Morgan	Underweight → Neutral
2023-05-18	Eingeleitet	TD Cowen	Outperform
2023-01-06	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-11-01	Hochstufung	Guggenheim	Neutral → Buy
2022-09-19	Fortgesetzt	H.C. Wainwright	Buy
2022-09-13	Herabstufung	Truist	Buy → Hold
2022-09-01	Eingeleitet	Raymond James	Outperform
2022-03-22	Herabstufung	Guggenheim	Buy → Neutral
2021-06-22	Eingeleitet	H.C. Wainwright	Buy
2021-05-21	Eingeleitet	UBS	Neutral
2021-03-16	Hochstufung	Truist	Hold → Buy
2021-03-09	Herabstufung	Wedbush	Outperform → Neutral
2021-03-08	Herabstufung	JP Morgan	Overweight → Underweight
2021-02-11	Hochstufung	JP Morgan	Underweight → Overweight
2020-10-27	Hochstufung	Wedbush	Neutral → Outperform
2020-10-14	Hochstufung	Guggenheim	Neutral → Buy
2019-11-08	Herabstufung	JP Morgan	Overweight → Underweight
2019-11-08	Herabstufung	Jefferies	Buy → Hold
2019-11-08	Herabstufung	SunTrust	Buy → Hold
2019-11-08	Herabstufung	Wedbush	Outperform → Neutral
2019-06-21	Herabstufung	Credit Suisse	Outperform → Neutral
2019-06-21	Herabstufung	Stifel	Buy → Hold
2018-12-20	Eingeleitet	H.C. Wainwright	Buy
2018-11-21	Eingeleitet	JP Morgan	Overweight
2018-07-19	Eingeleitet	Credit Suisse	Outperform
2018-04-04	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2018-03-27	Bestätigt	Stifel	Buy
2018-03-06	Bestätigt	Stifel	Buy
2018-02-15	Bestätigt	SunTrust	Buy
2018-01-23	Bestätigt	Credit Suisse	Outperform
2017-11-15	Eingeleitet	SunTrust	Buy
2017-11-09	Eingeleitet	Jefferies	Buy
2017-10-11	Bestätigt	RBC Capital Mkts	Outperform
2017-09-15	Eingeleitet	RBC Capital Mkts	Outperform

Alle ansehen

Anaptysbio Inc Aktie (ANAB) Neueste Nachrichten

Jul 22, 2025

AnaptysBio Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com

Jul 22, 2025

What analysts say about AnaptysBio Inc. stockOutstanding yields - jammulinksnews.com

Jul 22, 2025

How AnaptysBio Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser

Jul 22, 2025

Is AnaptysBio Inc. a good long term investmentConsistent high-yield stocks - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

What drives AnaptysBio Inc. stock priceFree Stock Market Knowledge Sharing - jammulinksnews.com

Jul 18, 2025

Jul 16, 2025

AnaptysBio, Inc.'s (NASDAQ:ANAB) Share Price Not Quite Adding Up - simplywall.st

Jul 16, 2025

Jul 15, 2025

What makes AnaptysBio Inc. stock price move sharplyShort Squeeze Radar - Newser

Jul 15, 2025

Why AnaptysBio Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser

Jul 15, 2025

Jul 14, 2025

AnaptysBio (ANAB) Soars 2.86% on Two Sigma Stake Increase - AInvest

Jul 14, 2025

AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB) - Seeking Alpha

Jul 14, 2025

(ANAB) Trading Report - news.stocktradersdaily.com

Jul 14, 2025

Jul 12, 2025

AnaptysBio (NASDAQ:ANAB) Stock Price Up 7.6%What's Next? - MarketBeat

Jul 12, 2025

Jul 07, 2025

Moody Aldrich Partners LLC Acquires New Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Jul 07, 2025

Jul 06, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Director Sells $493,202.25 in Stock - MarketBeat

Jul 06, 2025

Jul 04, 2025